For the compression of an elastic sphere with radius of R, Hertzian theory predicts the

relationship between applied load F and compression depth δ as [26] (2) where E * is the reduced Young’s modulus of the sphere. In this paper, E * is fitted from the load versus compression depth relation in the elastic regime by A 1331852 Equation 2. For different twin spacing, the value of E * keeps almost the same as 287.4 GPa. It is seen that the elastic response of nanosphere under compression is determined mainly by the local elastic properties under indenter. Therefore, for a given loading direction, the change of twin spacing does not affect the overall elastic response of nanosphere. And the reduced modulus is much larger than the theoretical prediction 153 GPa of the bulk single crystal material in <111 > direction [27]. In nanowires and nanoparticles, improved

elastic modulus and yield stress have also been observed [5, 13]. However, the introduction of TBs plays an important role in plastic deformation. The first load-drop, as marked by arrows in Figure 2, indicates the appearance of initial yield. The local peak load corresponding to the first load-drop may be considered as the yield load. It is found that, when the twin spacing decreases from 5.09 to 1.25 nm, the yield load increases from 0.28 to 0.62 μN. In the further development of plasticity, the compression load of the twinned Lorlatinib clinical trial nanosphere is significantly larger than that of the twin-free nanosphere for the same compression depth. The highly serrated load-compression response is indicative of dislocation activities inside the deformed nanospheres. ifoxetine To estimate the influence of TBs qualitatively, the strain energy GSK872 price stored in nanospheres up to a given compression depth (δ/R = 53.3%) is also shown in Figure 3. It is found that, the strain energy of twinned nanospheres increases clearly as the twin spacing decreases, reaching its maximum at the twin spacing of 1.88 nm, and then declines with further decreasing

twin spacing. Such characteristics are similar to those in nanotwinned polycrystalline materials [4, 9]. Figure 3 Strain energy of the deformed nanosphere as a function of twin spacing up to δ / R  = 53.3%. In order to understand the underlying strengthening mechanisms, we examine the atomistic structures in plastic stage for several samples, as shown in Figure 4. For a twin-free nanosphere, the plastic deformation begins with the nucleation of partial dislocations from the contact edge, and the dislocations then glide on 111 slip planes. Without experiencing obstacles from TBs, most partial dislocations easily glide to the opposite surface and annihilate here, forming surface steps. This process exhausts nucleated dislocations in nanosphere and reduces dislocation density, corresponding to the dislocation starvation mechanism.

Case presentation Written informed consent was obtained from the patient for publication of this case report. A 19 years old male patient with SNX-5422 clinical trial no significant past medical history presented to emergency room with abdominal pain and fatigue without complains of anorexia, nausea, vomiting, weight loss, jaundice or fever. Physical examination revealed skin LEE011 ic50 pallor, blood pressure 112/72, heart rate 92/min. Abdominal palpation revealed diffuse abdominal tenderness and splenomegaly 22 cm. The liver

and regional lymph nodes were not palpable. The remaining physical examination was unremarkable. Computed tomography (CT) scan of the abdomen showed massive splenomegaly and a solid mass with hypodense area in the tail of the pancreas (Figure 1). No liver lesions or abdominal lymphadenopathy were identified. Blood analysis revealed hemoglobin 10.6 gr/dl, white blood cell were 7000/mm3, platelet count 271000/mm3. Other laboratory analysis selleck including potassium, sodium, calcium, magnesium, phosphorus, blood urea nitrogen, creatinine, serum amylase, lipase, and liver chemistry were all within

normal range. Five hours later, blood pressure dropped to 86/55 and reduction of hemoglobin level to 5.9 gr/dl was detected. These findings considered indications for urgent explorative laparotomy. Sudden massive bleeding may cause acute hypovolemic shock even without reduction in the hemoglobin level. The patient

underwent an urgent explorative laparotomy. About 1.75 liters of blood were found in abdominal cavity. A large tumor arising from the tail of pancreas and local rupture of an enlarged spleen adjacent to the tumor were detected. Distal pancreatectomy and splenectomy were performed. The postoperative course was without any remarkable complications. Macroscopic pathology revealed a cystic mass measuring 8.2×6.5×6.0 cm in the tail of the pancreas and huge spleen measuring 23.5×15.5×6.3 cm (Figure 2). The pancreatic tumor was adhered to the hilar region of the spleen. The wall of the cystic mass was 1.4 cm. Microscopic pathology showed diffuse myofibroblastic for proliferation of the wall of the cystic mass with a variable inflammatory component surrounded by pancreatic parenchyma (Figure 3). The patient has been followed for 6 years without any clinical or radiographic evidence of recurrence. Figure 1 CT scan of the abdomen showed massive splenomegaly and a solid mass with hypodense area in the tail of the pancreas (arrows). Figure 2 Macroscopic pathology shows huge spleen measuring 23.5 × 15.5 × 6.3 cm and a cystic mass measuring 8.2 × 6.5 × 6.0 cm located in the tail of the pancreas adhered to the hilar region of the spleen (arrows). Microscopically, red pulp congestion and hyperplasia of the white pulp are shown in the left lower corner. Figure 3 Panoramic view of the IMT showing fibrin and cellular debris (A).

Furthermore, the production of IFN-γ by both T lymphocyte populations was higher in the SGE-3X group. Figure 5 Inflammatory profile during L. braziliensis infection after co-inoculation or pre-sensitization with saliva. BALB/c mice inoculated i.d. once (SGE-1X) or three times (SGE-3X) with Lutzomyia longipalpis SGE or CHIR98014 in vivo with PBS (control) were challenged with 105 L. braziliensis see more stationary phase promastigote forms. At the end of 7th week post-infection, ears

were harvested, processed and inflammatory leucocytes were sorted using specific antibodies. For intracellular cytokines, the cells were in vitro re-stimulated with lived parasites. Dot plots represent the percentages of CD4+CD3+ and CD4+IFN-γ+ cells (A–left panel), CD8+CD3+ and CD8+IFN-γ+ cells (B–right panel). Total number of CD4+ T cells (C) and CD4+IFN-γ+ cells (D) or CD8+ T cells (E) and CD8+IFN-γ+ cells (F), CD4+FOXP3+ cells (G), macrophages (H) and neutrophils (I) within the ears were identified by flow cytometry. Data represent the mean ± SEM and are representative of two different experiments (n = 4). # P < 0.05 compared with PBS. *P < 0.05 compared with the SGE-1X group. L. braziliensis infection induced the migration

of CD4+FOXP3+ regulatory T EPZ015666 nmr cells to the ear lesion (Figure  5G). However, SGE-1X treatment enhanced the number of CD4+FOXP3+ cells by three- to four-fold in the site of infection. Furthermore, in contrast with aforementioned cells, the number of CD4+FOXP3+ T cells was significantly reduced by one- to two-fold in the SGE-3X group. Our results also shown that, despite of SGE-1X presented the enhancement of neutrophil and macrophage, in the SGE-3X group both cell population was reduced. These reductions were, in average, 47% to macrophage (Figure  5H) and 48% to neutrophil (Figure  5I). These results therefore suggest that different saliva inoculums alters the inflammatory cell and cytokine composition at the site of parasite inoculation, and modulate the immune response during L. braziliensis infection. The protective effect of saliva is mediated by IFN-γ release Because

SGE-3X treatment protected the mice from parasitic infection (Figure  O-methylated flavonoid 3) and induced significant production of IFN-γ (Figure  4B) by increasing the emigration of CD4+ T cells and CD8+ T cells (Figure  5), we further investigated the impact of IFN-γ production on resistance against L. braziliensis infection. BALB/c mice sensitized with three treatments of saliva (SGE-3X) were depleted of IFN-γ by treatment with anti-IFN-γ mAb (R46A2 clone) and then were challenged with the parasite. As a control group, mice were also treated with a non-relevant IgG antibody. As shown in Figure  6A, SGE-3X mice treated with IgG control antibody developed minor edema that rapidly decreased with healing skin. Moreover, low parasitic titers were detected in this group (Figure  6B).

Baarn: Centraalbureau voor Schimmelcultures; 2009. 48. Korpi A, Pasanen A-L, Pasanen P, Kalliokoski P: Microbial growth and metabolism in house dust. Int Biodeter Biodegr 1997, 40:19–27.CrossRef 49. Scott JA, Straus NA, Wong B: Heteroduplex DNA fingerprinting of Penicillium brevicompactum from house dust. In Bioaerosols, fungi and mycotoxins: Health effects, assessment, prevention and control. Edited by: Johanning

E. Albany: Eastern New York Occupational and Environmental Health Clinic; 1999:335–342. 50. Noss I, Wouters IM, Visser M, Heederik DJ, Thorne PS, Brunekreef B, Doekes G: Evaluation of a low-cost electrostatic dust fall collector for indoor air endotoxin exposure assessment. Appl Environ Microbiol 2008, 74:5621–7.PubMedCrossRef click here 51. Pietarinen VM, Rintala H, Hyvärinen A, Lignell U, Kärkkäinen P, Nevalainen A: Quantitative PCR analysis of fungi and bacteria in building materials and comparison to culture-based analysis. J Environ Monit 2008, 10:655–663.PubMedCrossRef 52. Samson RA, Houbraken JS, Summerbell RC, Flannigan B, Miller JD: Chapter 5: Common

and important species of fungi and actinomycetes in indoor environments. In Microorganisms in home and indoor work environments: diversity, health impacts, investigation and control. Edited by: Flannigan B, Samson RA, Miller JD. Boca Raton: CRC Press; 2001:102–127. 53. Collado

J, Platas G, Paulus B, Bills GF: High-throughput culturing of fungi from plant check details litter by a dilution-to-extinction technique. FEMS Microbiol Ecol 2007, 60:521–533.PubMedCrossRef 54. Vesper S, McKinstry C, Cox D, Dewalt G: Correlation between ERMI values and other moisture and mold assessments of homes in the American Healthy Homes Survey. J Urban Health 2009, 86:850–860.PubMedCrossRef 55. Huttunen K, Rintala H, Hirvonen MR, Vepsalainen see more A, Hyvärinen A, Meklin T, Toivola M, Nevalainen A: Indoor air particles and bioaerosols before and after renovation of moisture-damaged buildings: the effect on biological activity and microbial flora. Environ Res 2008, 107:291–298.PubMedCrossRef 56. Sebastian A, Larsson L: Characterization of the microbial community in indoor environments: a Doramapimod order chemical-analytical approach. Appl Environ Microbiol 2003, 69:3103–3109.PubMedCrossRef 57. Haugland RA, Brinkman N, Vesper SJ: Evaluation of rapid DNA extraction methods for the quantitative detection of fungi using real-time PCR analysis. J Microbiol Methods 2002, 50:319–323.PubMedCrossRef 58. EMBL Nucleotide Sequence Database [http://​www.​ebi.​ac.​uk/​embl] 59. Felsenstein J: PHYLIP (Phylogeny Inference Package) version 3.6. [http://​www.​phylip.​com/​] Seattle: Department of Genome Sciences, University of Washington; 2005. 60.

anguillarum, contrary to other members of the LuxR family, this gene is expressed at low densities. This gene represses exopolysaccharide production, and regulates biofilm formation, metalloprotease, pigment production and serine biosynthesis [17]. In EPZ004777 the case of V. scophthalmi, which is a non-pathogenic vibrio, no virulence factors are shown to be regulated by this transcriptional regulator. At this moment, genome sequencing of the two V. scophthalmi strains used in this study is under process in our laboratory. Future work will involve transcriptome analysis of these mutants. Conclusions V. scophthalmi shares two quorum

sensing circuits, including the main transcriptional CRT0066101 datasheet regulator LuxR, with some pathogenic vibrios such as V. harveyi and V. anguillarum. However, contrary to these pathogenic vibrios no virulence factors (such as protease or siderophore production) were found to be quorum sensing regulated in this bacterium. Noteworthy, biofilm formation was altered in luxS and luxR mutants. In these mutants a different expression profile of membrane proteins were observed with respect to the wild type strain suggesting that quorum sensing could play Momelotinib a role in the adhesion and subsequent colonization of the fish by this bacterium. Further studies are needed in order to ascertain a similar behaviour of these mutants in vivo. Methods Bacterial strains,

culture media and growth conditions The bacterial strains and plasmids used in this study are listed in Table 3. The V. scophthalmi strains were grown at 30°C with agitation at 180 rpm in either marine broth (MB, Difco) (filtered through a 0.1 μm pore size to remove any precipitated salts that normally occur in this medium),

or tryptic soy broth (TSB, Difco) supplemented with NaCl to a final concentration of 2% (TSB2). Luria Bertani (LB) broth was used for growth of Escherichia coli. When needed, antibiotics were added to the media at the following final concentrations: 5 μg/ml and 25 μg/ml chloramphenicol for V. scophthalmi and E. coli, respectively, and 100 μg/ml Amylase ampicillin for E. coli. Table 3 Bacterial strains and plasmids used in this study Strain or plasmid Genotype and feature(s) Reference V. scophthalmi strains     A089 Wild type, turbot isolate (CECT 4638T) [2] A102 Wild type, turbot isolate (CECT 5965) [1, 2] A089_23 A089 ΔluxR mutant This study A089_88 A089_23 (pMMB207) “ A089_75 A089_23 (pMMB207::luxR) mutant “ A089_68 A089 ΔluxS mutant “ A089_84 A089_68 (pMMB207::luxS) mutant “ A089_92 A089_68 (pMMB207) “ A102_56 A102 ΔluxR mutant “ A102_78 A102_56 (pMMB207::luxR) mutant “ A102_90 A102_56 (pMMB207) “ A102_73 A102 ΔluxS mutant “ A102_87 A102_73 (pMMB207::luxS) mutant “ A102_94 A102_73 (pMMB207) “ A102_pACYC A102 (pACYC184) [11] A102_6.2 A102 (pACYC184::aiiA) “ A102_99 A102_73 (pACYC::luxS) This study E. coli strains     DH5α E. coli used for transformation: λpir Promega S17-1 E.

90 MMP1460 EhaM, energy-conserving hydrogenase A 0.56 ± 0.08 MMP1463 EhaP, energy-conserving hydrogenase A polyferredoxin subunit 0.64 ± 0.27 MMP0058 Mer, methylenetetrahydromethanopterin reductase 0.58 MMP1245 FwdF, formylmethanofuran dehydrogenase 0.20 MMP1247 Foretinib nmr FwdD, formylmethanofuran dehydrogenase 0.23 MMP1248 FwdA, formylmethanofuran dehydrogenase 0.27 MMP1249 FwdC, formylmethanofuran

dehydrogenase 0.28 ± 0.07 MMP1697 HdrA, heterodisulfide reductase 0.35 ± 0.18 MMP1696 VhuD, F420 non-reducing hydrogenase 0.35 ± 0.11 MMP1695 VhuG, F420 non-reducing hydrogenase 0.34 MMP1694 VhuA, F420 non-reducing hydrogenase 0.29 MMP0372 Mtd, F420-dependent methylenetetrahydromethanopterin dehydrogenase 0.35 ± 0.10 (0.89)b MMP1054 HdrC2, heterodisulfide reductase 0.33 MMP1053 HdrB2, heterodisulfide

reductase 0.33 ± 0.11 MMP1563 MtrB, methyltransferase 0.27 ± 0.16 MMP1564 MtrA, methyltransferase 0.09 MMP0127 Hmd, H2-dependent methylenetetrahydromethanopterin dehydrogenase -2.08 (-3.57)b MMP0125 Hypothetical protein -1.19 MMP0875 S-layer protein -1.25 MMP1176 Putative iron transporter subunit -0.83 MMP1206 GlnA, glutamine Selumetinib ic50 synthetase -0.35 aAverage of four log2 ratios: 15N-labeled H2-limited compared with PD0325901 solubility dmso 14N-labeled nitrogen-limited, 14N-labeled H2-limited compared with 15N-labeled nitrogen-limited, 15N-labeled H2-limited compared with 14N-labeled phosphate-limited, and 14N-labeled H2-limited compared with 15N-labeled phosphate limited. Standard deviations are given. Where protein abundance was affected by a second nutrient limitation

(other than H2), the average is from two ratios only, each H2-limited compared with the non-affecting nutrient limitation. bValues in parentheses represent measurements of mRNA by qRT-PCR. Table 2 Selected proteins with altered abundance under nitrogen limitation. ORF # Function Average log2 ratioa   Nitrogen fixation   MMP0853 NifH, nitrogenase reductase 2.29 ± 0.16 MMP0854 NifI1 1.68 ± 0.57 MMP0855 NifI2 2.10 ± 0.23 MMP0856 NifD, nitrogenase 2.45 ± 0.15 MMP0857 NifK, nitrogenase 2.03 ± 0.22 (7.09)b MMP0858 NifE 1.85 ± 0.42 MMP0859 NifN 1.65 ± 0.30 MMP0860 NifX 3.13 ± 0.60 MMP0446 NifX-NifB superfamily 1.05 ± 0.40   Ammonia transport and regulation   MMP0064 GlnK1 1.30 Aprepitant MMP0065 AmtB1 2.81 ± 0.31 MMP0066 GlnB 0.45 ± 0.41 MMP0067 GlnK2 1.59 ± 0.48   Ammonia assimilation   MMP1206 GlnA, glutamine synthetase 1.23   Molybdate transport   MMP0205 ModA, molybdate binding protein 2.11 ± 0.47 MMP0507 ModA, molybdate binding protein 2.24 ± 0.50 MMP0516 ModD, molybdate transporter subunit 0.73 ± 0.23 aAverage of four log2 ratios: 14N-labeled nitrogen-limited compared with 15N-labeled H2-limited, 15N-labeled nitrogen-limited compared with 14N-labeled H2-limited, 15N-labeled nitrogen-limited compared with 14N-labeled phosphate-limited, and 14N-labeled nitrogen-limited compared with 15N-labeled phosphate limited. Standard deviations are given.

One of the challenges of this approach is the frequent and unexpected amplification of contaminating template DNA, as observed in control reactions. Another potential problem with targeting 16S rRNA pathogen specific sequences is unexpected polymorphisms. Hence, naturally occurring variants may not be represented on the microarray, and failure to Selleckchem PRN1371 detect the variants would represent false negatives [11]. Another common PCR based approach detects pathogen type by amplification of a specific set of genetic markers that are measured on an array that has several probes for genes from a set of organisms. Such tests have been

used for food-borne bacteria such as E. coli O157:H7 [12], viruses [13] and mixtures of pathogens [14]. The drawback of using this approach with multiplex PCR primers sets is the generation of spurious products [11]. Array based technologies using 70-mer oligonucleotide buy Tideglusib probes derived from pathogen specific genes have similar factors that require consideration. For instance, viral detection using a microarray composed of 1,600 unique viral oligonucleotides (70-mers) derived from 140 distinct viral genomes has been previously demonstrated [15] as a powerful viral detection mechanism,

but the drawback of this strategy is that only the group of known pathogen-specific genes will be queried. Given the enormous spectrum of genetic possibilities, only a highly parallel field deployable technology that is universal in nature has near-term potential to address these needs. The initial vision for a universal DNA microarray was a matrix of oligonucleotide containing features with unique n-mer probes [16]. This matrix could in theory be used to query a biological sample for the presence of any nucleic acid sequence. This technique requires constructing an array that contains 4n features. Larger values of n infuse greater specificity into the arrayed probes, but as n increases the number of required features grows rapidly. This universality check details is obtained

by synthesizing a combinatorial n-mer array containing all 4n possible sequences of length n [17]. The key issue is to find a value of n that is large enough to afford sufficient hybridization specificity, yet small enough to be practically fabricated and analyzed. We have previously demonstrated the utility of a genome sequence-independent microarray for identifying genetic differences [18, 19]. The initial prototype of universal arrays used oligonucleotide probe lengths of 12 and 13 bases. From 412 possible probes, a subset of 14,283 probes was synthesized using in situ synthesis technology and digital optical chemistry (DOC) [20–22]. Fluorescently labelled genomic DNA was hybridized to produce unique informative Smad inhibitor patterns (i.e. bio-signatures) on a test set of pathogens and host (Bacillus subtilis, Yersinia pestis, Streptococcus peumoniae, Bacillus anthracis, and Homo sapiens).

TEG analysis is carried out within 4 minutes of blood sample

collection. The whole blood sample is placed in a manufacturer-supplied vial containing kaolin, and 0.35 ml of the blood #Enzalutamide randurls[1|1|,|CHEM1|]# sample is added to a cup, followed by adjustment of the temperature setting to the patient’s temperature. TEG assay is then started and stopped when reaching full tracing. A number of parameters are generated from the TEG tracing, each representing an aspect of hemostasis. The R value is the time from the beginning to the onset of clot formation, representing the activity of enzymatic clotting factors. The α angle is the angle between the tangent line and the horizontal line of the tracing, representing the activity of fibrinogen. The maximal

amplitude (MA) is the overall clot strength, indicating the platelet activity. Patients in the goal-directed group were managed with goal-directed transfusion protocol based on TEG results (Figure 1). The protocol was developed by a group of surgeons, SICU specialists, and transfusion specialists, and was introduced to all surgeons and SICU specialists of our department before its implementation in November 2010. The algorithm of the protocol was shown as hard copies in SICU, and two attending surgeons and two SICU AMG510 clinical trial specialists ensured utilization of the protocol as the leaders of abdominal trauma management. In specific, standard TEG test was ordered by the treating surgeon or SICU specialist when the patient with abdominal trauma was admitted to SICU, or had active bleeding at ED, operation room (OR), or SICU. Whole blood sample was transferred immediately to the SICU of our department, where it was analyzed. Results were fed back via in-hospital communication system to the treating surgeon or SICU specialist, who determined further transfusion management according to the goal-directed transfusion protocol. The goal-directed transfusion might occur at ED, OR, or SICU. Subsequent

Phosphoglycerate kinase TEG tests were ordered until the patient had no active bleeding or coagulopathy. Figure 1 Goal-directed transfusion protocol via TEG. Data collection Data of all included patients from ED, SICU, OR, blood bank, and laboratory were linked. Demographic characteristics (age and gender), injury severity indices (injury mechanism, injured organs, injury severity score [ISS], abdominal abbreviated injury scale [AIS]) were collected. Administration of component blood products within 24 hours of ED admission was also recorded. Clinical and laboratory parameters of interest included vital signs (body temperature, heart rate, and systolic blood pressure), arterial blood gas results (pH, lactate, and base excess), blood cell counts (hemoglobin concentration, RBC count, and platelet count), albumin and calcium concentration, international normalized ratio (INR) and activated partial thromboplastin time (aPTT) at ED admission and 24 h.

It is also possible that ARS-1620 concentration a salient infection occurred earlier in life, was

cleared, but the infection sequelae are responsible for clinical state. Such infections, in the case of known viruses, can in many cases be detected via serology. Finally, it is possible that ISRIB manufacturer chronic fatiguing illness represents a similar clinical endpoint for multiple different disease etiologies (which may or may not be infectious in nature) and that etiological heterogeneity effectively lessens the probability of detection. Conclusions Our results show a weakly significant difference between affected and unaffected twins in the cross-sectional prevalence of GBV-C viremia. Whether this is etiologically important or due to chance or bias is not clear. However, the possible connection between GBV-C and CFS deserves further study in larger samples. Methods Subjects The protocol was approved in advance by the ethical review board at UNC-CH and the Karolinska Institutet and all subjects provided written informed consent. The parent study is described elsewhere [22–24], and we have previously shown that there were no differences in gene expression in peripheral blood BAY 1895344 in monozygotic twins discordant for chronic fatigue [12]. We screened ~61,000 individual twins from the Swedish

Twin Registry for the symptoms of fatiguing illness. All twins were born in Sweden of Scandinavian ancestry. Of 5,597 monozygotic twin pairs where both were alive and had provided usable responses to CFS screening questions, we identified 140 pairs of twins who met preliminary inclusion criteria: born 1935-1985, classified as a monozygotic twin based on questionnaire responses [25], and discordant for chronic fatiguing illness (i.e., one twin reported substantial fatigue and the other

twin was evidently well). A telephone interview using a standardized script was used to assess eligibility for participation. CHIR-99021 manufacturer Twins who remained eligible both attended a half-day clinical assessment by a specially trained physician at the Karolinska Institutet in Stockholm. At this visit, a CFS-focused medical assessment was conducted that included standardized medical history, physical examination, and screening biochemical, hormonal, and hematological studies in accordance with international recommendations [1]. Of 140 monozygotic and preliminarily discordant twin pairs, one or both twins declined participation in 23 pairs, 25 pairs were concordant for CFS-like illness, and inclusion criteria were not met in 35 pairs (e.g., chronic fatigue had resolved or an illness that could explain fatiguing symptoms such as neoplasia had emerged).

J Clin Microbiol 1981,14(3):298–303.PubMed 8. Delgado-Viscogliosi P, Simonart T, Parent V, Marchand G, Dobbelaere M, Pierlot E, Pierzo V, Menard-Szczebara F, Gaudard-Ferveur E, Delabre K: Rapid method for enumeration of viable Legionella Selleckchem GSK3326595 pneumophila and other Legionella

spp. in water. Appl Environ Microbiol NVP-LDE225 chemical structure 2005,71(7):4086–4096.PubMedCrossRef 9. Alleron L, Merlet N, Lacombe C, Frere J: Long-term survival of Legionella pneumophila in the viable but nonculturable state after monochloramine treatment. Curr Microbiol 2008,57(5):497–502.PubMedCrossRef 10. Evstigneeva A, Raoult D, Karpachevskiy L, La Scola B: Amoeba co-culture of soil specimens recovered 33 different bacteria, including four new species and Streptococcus pneumoniae . Microbiology 2009,155(Pt 2):657–664.PubMedCrossRef 11. Rowbotham TJ: Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae. J Clin Pathol 1980,33(12):1179–1183.PubMedCrossRef 12. La Scola B, Mezi L, Weiller PJ, Raoult D: Isolation of Legionella anisa using an amoebic coculture procedure. J Clin Microbiol 2001,39(1):365–366.PubMedCrossRef 13. Rowbotham TJ: Isolation of Legionella pneumophila from clinical specimens via amoebae, and the interaction of those and other isolates

with Poziotinib amoebae. J Clin Pathol 1983,36(9):978–986.PubMedCrossRef 14. Garcia MT, Jones S, Pelaz C, Millar RD, Abu Kwaik Y: Acanthamoeba polyphaga resuscitates viable non-culturable Legionella pneumophila after disinfection. Environ Microbiol 2007,9(5):1267–1277.PubMedCrossRef 15. La Scola B, Birtles RJ, Greub G, Harrison TJ, Ratcliff RM, Raoult D: Legionella drancourtii sp. nov., a strictly intracellular amoebal pathogen. Int J Syst Evol Microbiol 2004,54(Pt 3):699–703.PubMedCrossRef 16. Fallon RJ, Rowbotham TJ: Microbiological investigations into an outbreak of pontiac fever due to Legionella micdadei associated with use of a whirlpool. J Clin Pathol 1990,43(6):479–483.PubMedCrossRef 17. Thomas V, Herrera-Rimann K, Blanc DS, Greub G: Biodiversity of amoebae and amoeba-resisting bacteria in a hospital water network. Appl Environ Microbiol 2006,72(4):2428–2438.PubMedCrossRef

18. Casati S, Gioria-Martinoni 17-DMAG (Alvespimycin) HCl A, Gaia V: Commercial potting soils as an alternative infection source of Legionella pneumophila and other Legionella species in Switzerland. Clin Microbiol Infect 2009,15(6):571–575.PubMedCrossRef 19. Helbig JH, Bernander S, Castellani Pastoris M, Etienne J, Gaia V, Lauwers S, Lindsay D, Luck PC, Marques T, Mentula S: Pan-european study on culture-proven Legionnaires’ disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis 2002,21(10):710–716.PubMedCrossRef 20. Moffat JF, Tompkins LS: A quantitative model of intracellular growth of Legionella pneumophila in Acanthamoeba castellanii . Infect Immun 1992,60(1):296–301.PubMed 21.